Capula Management’s Chemed CHE Stock Holding History

Capula Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-469	Closed	-$252K	–	478
2023 Q1	$252K	Buy	+469	New	+$239K	﹤0.01%	566

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Capula Management's CHE Position: Q2 2023 in Review

Capula Management sold out of Chemed (CHE) in Q2 2023, closing a stake of 469 shares — an estimated $252K sold.

Capula Management first reported a position in CHE in Q1 2023 and held it in 1 quarter. The position peaked at $252K in Q1 2023. 464 funds tracked by Wall St. Rank hold CHE as of Q2 2023.

Capula Management reported no remaining Chemed position as of Q2 2023 after selling out during the quarter.
Capula Management sold 469 Chemed shares in Q2 2023, an estimated $252K.
Capula Management first reported a position in Chemed in Q1 2023 and held it in 1 quarter.
Capula Management's Chemed position peaked at $252K in Q1 2023.
464 funds tracked by Wall St. Rank held Chemed as of Q2 2023.

Based on Capula Management's 13F filing for Q2 2023, filed 14 Aug 2023.